-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Cyclacel Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2010 to Q3 2025.
- Cyclacel Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 1.91M shares, a 4180% increase year-over-year.
- Cyclacel Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 22.3M shares, a 529% increase from 2023.
- Cyclacel Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 3.55M shares, a 68.5% decline from 2022.
- Cyclacel Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 11.3M shares, a 26.1% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)